“pharma”的搜索结果

在地名、地址与坐标之间转换，搜索周边设施，查询驾车、步行和骑行路线及耗时，也可查看当地时区与时间，用于旅行出行规划和指定区域的设施调查。

• 寻找附近的咖啡馆或药店
• 查询两地之间的路线与耗时
• 在地名与坐标之间转换

Turn small-molecule structures into numerical features for similarity searches and models that predict activity or properties. Using Molfeat, the skill covers representation choices, invalid inputs, alignment with experimental labels, and saving feature-generation settings for reuse.

中文简介正在准备中。当前显示英语简介。

• Prepare molecular features for activity or property prediction
• Choose molecular representations for similarity searches
• Keep experimental labels aligned after rejecting invalid molecules

Continue regulatory research when government pages or PDFs cannot be retrieved. Use alternative sources to draft compliance checklists, clearly distinguish the basis of each finding, and identify requirements that need confirmation from the relevant authority.

中文简介正在准备中。当前显示英语简介。

• Continue research when government PDFs cannot be retrieved
• Draft compliance checklists from secondary sources
• Organize preliminary notes on pharmacy compliance

Continue regulatory research when official sources cannot be accessed. The skill uses alternative sources or established regulatory knowledge to draft summaries and checklists, while documenting limitations and identifying the need for verification against current official requirements.

中文简介正在准备中。当前显示英语简介。

• Continuing regulatory research after source access failures
• Drafting pharmacy and healthcare compliance checklists
• Documenting unavailable sources and alternative evidence

Look up how genetic differences affect medication response using ClinPGx. Retrieve gene–drug relationships, clinical guidelines, genetic variant functions, and drug labels to gather evidence for research and reviews of genotype-based dosing recommendations.

中文简介正在准备中。当前显示英语简介。

• Investigate gene–drug relationships
• Review guidelines for genotype-based dosing
• Compare genetic variant frequencies across populations

Query BindingDB for measured drug-target binding affinities (Ki, Kd, IC50, EC50). Search by target (UniProt ID), compound (SMILES/name), or pathogen. Essential for drug discovery, lead optimization, polypharmacology analysis, and structure-activity relationship (SAR) studies.

中文简介正在准备中。当前显示原文说明。

Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for transplant matching, neoantigen prediction, or pharmacogenomic screening.

中文简介正在准备中。当前显示原文说明。

Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). ...

中文简介正在准备中。当前显示原文说明。

Generates complete FAERS pharmacovigilance study designs for one-drug whole-profile safety mapping using signal detection, subgroup analysis, onset/seriousness characterization, and conservative label-gap interpretation.

中文简介正在准备中。当前显示原文说明。

Evidence-based medical knowledge and research mentor grounded in the Bian Que tradition. Covers clinical reasoning, diagnostic thinking (望闻问切), pharmacology, pathology, differential diagnosis, medical literature appraisal, and the philosophy of early intervention. Trigger whenever users ask about medicine, clinical science, drugs, disease mechanisms, diagnosis, lab interpretation, treatment comparison, or health sciences. Even without explicit research framing, trigger on any topic touching disease, therapeutics, or clinical decision-making. Part of the AIPOCH Medical Research Skill Hub.

中文简介正在准备中。当前显示原文说明。

Generates complete FAERS pharmacovigilance study designs for multi-drug or class-level safety comparison inside one predefined SOC or AE family using active comparators, disproportionality analysis, subgroup characterization, and reviewer-facing evidence control.

中文简介正在准备中。当前显示原文说明。

Use when evaluating stocks through Dan Bin's long-term compounder lens: buy great companies, hold through volatility, and let time do the work. Focus on consumer, pharma, and tech compounders.

中文简介正在准备中。当前显示原文说明。

Design Thinking method coaching knowledge across all nine methods including per-method techniques, deep expertise, and industry context (energy, financial services, healthcare, manufacturing, nonprofit and social impact, pharmaceuticals and life sciences, professional services, public sector, retail and CPG)

中文简介正在准备中。当前显示原文说明。

Routes finance: Bigdata/RavenPack, US fundamentals/yfinance, A-share news/policy, sector Top N/公告, Gangtise/岗底斯 setup. Reads one bundled specialist. Pharma reporting and general argument review keep their own direct entries.

中文简介正在准备中。当前显示原文说明。

Searches molecular libraries for substructure matches using SMARTS patterns with explicit handling of recursive SMARTS, ring membership, aromaticity dialect, vector binding, atom map indices, and reactive/PAINS/REOS/Brenk filter catalogs. Use when filtering compounds by pharmacophore features, functional groups, scaffold matches, or screening for assay-interference / structural alerts.

中文简介正在准备中。当前显示原文说明。

Runs cis-pQTL Mendelian randomization for drug-target validation using UKB-PPP (Olink), deCODE (SomaScan), Fenland, INTERVAL, ARIC, and FinnGen-PPP proteomes plus colocalization triangulation, phenome-wide on-target adverse-effect scans, cross-platform Olink/SomaScan replication, and PAV (protein-altering variant) sensitivity. Use when nominating or de-risking a drug target from plasma-proteome GWAS, mimicking pharmacological inhibition via cis-pQTL instruments, separating shared-causal from LD-confounded signal under the Schmidt 2020 cis-MR framework, screening on-target adverse phenotypes pheWAS-style, or producing publication-grade STROBE-MR plus PP.H4 evidence for a target gene.

中文简介正在准备中。当前显示原文说明。

Query CPIC pharmacogenomics clinical annotations database

中文简介正在准备中。当前显示原文说明。

The FDA Adverse Event Reporting System (FAERS) is a database used for the spontaneous reporting of adverse events and medication errors related to human drugs and therapeutic biological products. faers pacakge serves as the interface between the FAERS database and R. Furthermore, faers pacakge offers a standardized approach for performing pharmacovigilance analysis.

中文简介正在准备中。当前显示原文说明。

Access ClinPGx pharmacogenomics data (successor to PharmGKB). Query gene-drug interactions, CPIC guidelines, allele functions, for precision medicine and genotype-guided dosing decisions.

中文简介正在准备中。当前显示原文说明。

Query the ClinPGx (formerly PharmGKB) REST API plus the CPIC PostgREST companion API for pharmacogenomic clinical annotations, CPIC/DPWG dosing guidelines, gene-drug pairs, variant-drug associations, FDA/EMA drug labels, and PGx pathways. Two-host architecture: api.clinpgx.org for annotation records, api.cpicpgx.org for genotype→recommendation lookups. No auth. For germline pathogenicity use clinvar-database; for somatic cancer PGx use cosmic-database or opentargets-database; for drug bioactivity use chembl-database-bioactivity.

中文简介正在准备中。当前显示原文说明。

Query DDInter drug-drug interactions via REST API (1.7M+ interactions, 2,400+ drugs). Search by drug name/ID for severity (major/moderate/minor), mechanisms, and clinical recommendations. No auth. For FDA labeling use dailymed-database; for pharmacogenomics use clinpgx-database.

中文简介正在准备中。当前显示原文说明。

Query IUPHAR/BPS Guide to Pharmacology (GtoPdb) for receptor-ligand interactions, target/ligand metadata, families, and approved drugs. Affinities (pKi/pIC50/pKd), action (Agonist/Antagonist/etc.), species, structures (SMILES/InChI). No auth. Always resolve targets via geneSymbol/accession; most metadata lives in sub-resources (/databaseLinks, /structure, /synonyms).

中文简介正在准备中。当前显示原文说明。

Molecular featurization hub (100+ featurizers) for ML. SMILES to fingerprints (ECFP, MACCS, MAP4), descriptors (RDKit 2D, Mordred), pretrained embeddings (ChemBERTa, GIN, Graphormer), pharmacophores. Scikit-learn compatible with parallelization/caching. For QSAR, virtual screening, similarity, and molecular DL.

中文简介正在准备中。当前显示原文说明。

Guidelines for clinical decision support (CDS) documents: biomarker-stratified cohort analyses and GRADE-graded treatment reports. Covers structure, executive summaries, evidence grading (1A–2C), stats (HR, CI, survival), and biomarker integration. Use for pharma research docs, clinical guidelines, regulatory submissions.

中文简介正在准备中。当前显示原文说明。